Acute Myeloid Leukemia Clinical Trial
A Telehealth Advance Care Planning Intervention for Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
Summary
This is a pilot study to evaluate the usability and feasibility of a telehealth-delivered advance care planning intervention among 20 older patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), their caregivers, and oncologists.
Full Description
Older adults with AMLamd MDS are more likely to receive aggressive care and less likely to utilize hospice at the end-of-life. Advance care planning (ACP) intervention delivered through telehealth may improve patient-reported outcomes and end-of-life care in this population. This pilot study seeks to evaluate the usability and feasibility of a telehealth-delivered advance care planning intervention. We will adapt the Serious Illness Care Program.
Eligibility Criteria
Inclusion Criteria for Patients:
Age ≥60 years (conventional definition of older age in AML/MDS)
AML or MDS diagnosis
Being managed in the outpatient settings
Able to provide informed consent
English-speaking
Inclusion criteria for caregivers:
Age ≥21 years
Selected by patient when asked if there is a "family member, partner, friend, or caregiver with whom you discuss or who can be helpful in health-related matters"
Able to provide informed consent
English-speaking
Exclusion Criteria: N/A
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Rochester New York, 14642, United States
How clear is this clinincal trial information?